Metformin: a review of its potential indications
YW Wang, SJ He, X Feng, J Cheng… - Drug design …, 2017 - Taylor & Francis
Metformin is the most commonly prescribed drug for type 2 diabetes mellitus. In recent years,
in addition to glucose lowering, several studies have presented evidence suggesting some …
in addition to glucose lowering, several studies have presented evidence suggesting some …
Metformin: a review of its potential indications
W Yi-Wei, H Si-Jia, F Xiao, J Cheng… - Drug Design …, 2017 - search.proquest.com
Metformin is the most commonly prescribed drug for type 2 diabetes mellitus. In recent years,
in addition to glucose lowering, several studies have presented evidence suggesting some …
in addition to glucose lowering, several studies have presented evidence suggesting some …
[引用][C] Metformin: a review of its potential indications
YW Wang, SJ He, X Feng, J Cheng, YT Luo… - Drug Design …, 2017 - cir.nii.ac.jp
Metformin: a review of its potential indications | CiNii Research CiNii 国立情報学研究所 学術
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
Metformin: a review of its potential indications.
YW Wang, SJ He, X Feng, J Cheng, YT Luo… - Drug Design …, 2017 - europepmc.org
Metformin is the most commonly prescribed drug for type 2 diabetes mellitus. In recent years,
in addition to glucose lowering, several studies have presented evidence suggesting some …
in addition to glucose lowering, several studies have presented evidence suggesting some …
Metformin: a review of its potential indications
YW Wang, SJ He, X Feng, J Cheng, YT Luo… - Drug Design …, 2017 - go.gale.com
Metformin is the most commonly prescribed drug for type 2 diabetes mellitus. In recent years,
in addition to glucose lowering, several studies have presented evidence suggesting some …
in addition to glucose lowering, several studies have presented evidence suggesting some …
[HTML][HTML] Metformin: a review of its potential indications
YW Wang, SJ He, X Feng, J Cheng… - Drug Design …, 2017 - ncbi.nlm.nih.gov
Metformin is the most commonly prescribed drug for type 2 diabetes mellitus. In recent years,
in addition to glucose lowering, several studies have presented evidence suggesting some …
in addition to glucose lowering, several studies have presented evidence suggesting some …
Metformin: a review of its potential indications
YW Wang, SJ He, X Feng, J Cheng… - Drug design …, 2017 - pubmed.ncbi.nlm.nih.gov
Metformin is the most commonly prescribed drug for type 2 diabetes mellitus. In recent years,
in addition to glucose lowering, several studies have presented evidence suggesting some …
in addition to glucose lowering, several studies have presented evidence suggesting some …
Metformin: a review of its potential indications
YW Wang, SJ He, X Feng, J Cheng, YT Luo… - Drug Design …, 2017 - dovepress.com
Metformin is the most commonly prescribed drug for type 2 diabetes mellitus. In recent years,
in addition to glucose lowering, several studies have presented evidence suggesting some …
in addition to glucose lowering, several studies have presented evidence suggesting some …
Metformin: a review of its potential indications.
YW Wang, SJ He, X Feng, J Cheng, YT Luo… - Drug Design …, 2017 - europepmc.org
Metformin is the most commonly prescribed drug for type 2 diabetes mellitus. In recent years,
in addition to glucose lowering, several studies have presented evidence suggesting some …
in addition to glucose lowering, several studies have presented evidence suggesting some …